1What the GAMP software categories are.
GAMP 5 is ISPE’s guide to a risk-based approach to compliant GxP computerised systems. Its Second Edition was published in July 2022 and is written for regulated companies, suppliers and regulators.¹ The software categories sit in Appendix M4, “Categories of Software and Hardware”.² They group components by one question: “What complexity of activity has to be done to create the component for this specific application?”³
The names have changed since GAMP 4. ISPE’s 2026 article on categorisation traces GAMP 4’s “operating systems, firmware, standard software packages, configurable software packages and custom (bespoke) software” to the Second Edition’s “infrastructure software, tools and IT services, standard system components, configured components and custom applications and components”.³ Firmware, numbered 2 in GAMP 4,⁴ has no counterpart in the new list, and ISPE’s own articles keep the numbers 1, 3, 4 and 5.⁵
| Category | Second Edition name | GAMP 4 name | Examples in ISPE publications |
|---|---|---|---|
| 1 | Infrastructure software, tools and IT services | Operating system | Operating systems, libraries, development tools and embedded components, which covers most open-source software;⁶ platform as a service;⁷ infrastructure as code⁸ |
| 2 | Not in the Second Edition’s list | Firmware | GAMP 4 managed custom firmware as Category 5⁴ |
| 3 | Standard system components | Standard software packages | Off-the-shelf software used without configuration⁵⁹ |
| 4 | Configured components | Configurable software packages | Configurable workflows that do not require programming¹⁰ |
| 5 | Custom applications and components | Custom (bespoke) software | Robotic process automation scripts;¹¹ bespoke system interfaces⁵ |
ISPE’s functional risk article uses the categories as a rough guide to the likelihood of failure: low for non-configured off-the-shelf software, medium for configured software and high for customised software. It adds that “These are guidelines only”: complex configuration can raise the likelihood, and simple custom software can be medium.⁹
2Categories describe components, not systems.
The Second Edition makes this explicit. ISPE’s summary of the changes says computerised systems “are generally made up of a combination of components from different categories”, that “categories 3-5 should be viewed as a continuum”, and that the category “is just one factor in a risk-based approach”, with life cycle activities scaled by the system’s GxP impact, complexity and novelty.¹²
ISPE’s 2026 article on categorisation quotes Section 12.2 of the guide: “Categorization is not intended to provide a checklist approach to validation.” The guide recommends whole-system categorisation only to help define the approach to supplier assessment; everywhere else, categories apply to the components that make up a system. The article’s example of why judgement matters: “a very complex configured component might have a higher likelihood of residual defects than a very simple custom component”.³ PIC/S made the same point under GAMP 4 in 2007: “Many systems span the category levels.”⁴
3Which category is a LIMS, eQMS or MES.
None of these sources assigns a LIMS, eQMS or MES a single category, and under the Second Edition’s component approach none would have one. A typical configurable platform breaks down like this.
| Part of the system | Usual category | Basis |
|---|---|---|
| Operating system, database, libraries and cloud platform | 1 | Infrastructure software and platform as a service⁶⁷ |
| Standard functions used as delivered | 3 | Non-configured components⁵ |
| Workflows, forms, roles and limits set by configuration | 4 | Configurable workflows that do not require programming¹⁰ |
| Scripts and bespoke interfaces | 5 | Scripts as small custom applications; bespoke interfaces¹¹⁵ |
Regulators look past the platform’s category to what it is used for. FDA says each CGMP workflow is an intended use to be validated, and that qualifying an MES platform “does not demonstrate that a given MPCR generated by the MES contains the correct calculations”; validating the workflow does.¹³ MHRA says accepting “vendor-supplied validation data in isolation of system configuration and users intended use is not acceptable”.¹⁴ ISPE’s 2013 white paper on clinical systems, written under the first edition, made the same split for electronic data capture: a validated platform, then trial-specific configuration validated for each trial, as “two separate life cycles”.¹⁰
4What the regulations say about categories.
No regulation sets GAMP categories. EU GMP Annex 11 (2011) says “The application should be validated; IT infrastructure should be qualified”, and that the extent of validation should rest on “a justified and documented risk assessment”. It asks users to review the documentation supplied with commercial off-the-shelf products against their requirements (clause 3.3), and for bespoke or customised systems it expects a process for “formal assessment and reporting of quality and performance measures for all the life-cycle stages” (clause 4.6).¹⁵
FDA’s data integrity guidance says “The extent of validation studies should be commensurate with the risk posed by the automated system.”¹³ Its final guidance on computer software assurance, issued on 3 February 2026 for software used in medical device production or quality management systems, sorts features, functions and operations into “high process risk” and “not high process risk”, and names GAMP 5 Second Edition as one industry resource on testing and validation methods.¹⁶ The categories are a tool for applying those requirements, not a substitute for the risk assessment they call for.
5How it runs in Seal.
Seal’s validation and AI assurance guide sets assurance at three boundaries: the managed platform, your configured process, and custom logic and connected systems. It says software categorisation follows the actual components and their use, so a configurable platform does not give every script, integration or deployment the same GAMP category, and the scope and assurance rationale are agreed in your validation plan.
The computer system assurance blueprint starts from intended use and function risk, and releases against a fixed configuration baseline. In the LIMS blueprint, the user requirements, functional and design specifications, configuration specification, verification results and approval can be kept together in Seal and updated with the configuration they describe.
References
- 1ISPE GAMP 5 Guide: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition), ISPE, July 2022. https:/
/ ispe. org/ publications/ guidance- documents/ gamp- 5- guide- 2nd- edition (read 6 November 2026) - 2ISPE GAMP 5 Second Edition, table of contents, ISPE, 2022. https:/
/ ispe. org/ sites/ default/ files/ publications/ guidance- documents/ 2022- TOC/ ISPE- GAMP5- Ed2_ TOC. pdf (read 6 November 2026) - 3When Is a Category Not a Category?, Pharmaceutical Engineering, ISPE, January/February 2026. https:/
/ ispe. org/ pharmaceutical- engineering/ january- february- 2026/ when- category- not- category (read 6 November 2026) - 4PI 011-3, Good Practices for Computerised Systems in Regulated “GXP” Environments, PIC/S, 25 September 2007. https:/
/ picscheme. org/ docview/ 3444 (read 6 November 2026) - 5Pharma 4.0: Plug & Produce Architectural Principles, white paper, ISPE, 5 December 2024. https:/
/ ispe. org/ pharmaceutical- engineering/ white- papers/ pharma- 40- plug- produce- architectural- principles (read 6 November 2026) - 6GAMP Considerations When Relying on Open-Source Software, Pharmaceutical Engineering, ISPE, March/April 2022. https:/
/ ispe. org/ pharmaceutical- engineering/ march- april- 2022/ gamp- considerations- when- relying- open- source- software (read 6 November 2026) - 7Continuous Operational Control of PaaS in GxP Environments, Pharmaceutical Engineering, ISPE, July/August 2026. https:/
/ ispe. org/ index. php/ pharmaceutical- engineering/ july- august- 2026/ continuous- operational- control- paas- gxp- environments (read 6 November 2026) - 8The Use of Infrastructure as Code in Regulated Companies, Pharmaceutical Engineering, ISPE, January/February 2024. https:/
/ ispe. org/ pharmaceutical- engineering/ january- february- 2024/ use- infrastructure- code- regulated- companies (read 6 November 2026) - 9Removing the Frustration from Functional Risk Management, Pharmaceutical Engineering, ISPE, January/February 2025. https:/
/ ispe. org/ pharmaceutical- engineering/ january- february- 2025/ removing- frustration- functional- risk- management (read 6 November 2026) - 10The Application of GAMP 5 to the Implementation and Operation of a GxP Compliant Clinical System, white paper, ISPE, 1 September 2013. https:/
/ ispe. org/ pharmaceutical- engineering/ white- papers/ application- gampr- 5- implementation- and- operation- gxp- compliant- clinical (read 6 November 2026) - 11A GAMP Approach to Robotic Process Automation, Pharmaceutical Engineering, ISPE, May/June 2020. https:/
/ ispe. org/ pharmaceutical- engineering/ gamp- approach- robotic- process- automation (read 6 November 2026) - 12What You Need to Know About GAMP 5 Guide, 2nd Edition, Pharmaceutical Engineering, ISPE, January/February 2023. https:/
/ ispe. org/ pharmaceutical- engineering/ january- february- 2023/ what- you- need- know- about- gampr- 5- guide- 2nd- edition (read 6 November 2026) - 13Data Integrity and Compliance With Drug CGMP: Questions and Answers, Guidance for Industry, FDA, December 2018. https:/
/ www. fda. gov/ media/ 119267/ download (read 6 November 2026) - 14‘GXP’ Data Integrity Guidance and Definitions, Revision 1, MHRA, March 2018. https:/
/ assets. publishing. service. gov. uk/ media/ 5aa2b9ede5274a3e391e37f3/ MHRA_ GxP_ data_ integrity_ guide_ March_ edited_ Final. pdf (read 6 November 2026) - 15EudraLex Volume 4, Annex 11: Computerised Systems, European Commission, in operation since 30 June 2011. https:/
/ health. ec. europa. eu/ system/ files/ 2016- 11/ annex11_ 01- 2011_ en_ 0. pdf (read 6 November 2026) - 16Computer Software Assurance for Production and Quality Management System Software, Guidance for Industry and FDA Staff, FDA, 3 February 2026. https:/
/ www. fda. gov/ media/ 188844/ download (read 6 November 2026)
AQuestions and answers
What happened to GAMP Category 2?
Category 2 was firmware in GAMP 4. The Second Edition’s list of categories has no firmware category, and ISPE’s publications keep the numbers 1, 3, 4 and 5 for the rest. Under GAMP 4, configurable firmware was recorded with its configuration and custom firmware was managed as Category 5.
Is a SaaS application Category 1 or Category 4?
The hosting platform beneath it is treated as Category 1 infrastructure, which ISPE says needs good IT practice rather than application-style IQ, OQ and PQ. The application itself is categorised by its components: what you configure is usually Category 4, and any scripts or custom code Category 5. Annex 11 expects the application to be validated and the infrastructure qualified.
Does the software category decide how much testing is needed?
Not by itself. The Second Edition calls the category one factor in a risk-based approach and scales life cycle activities by the GxP impact, complexity and novelty of the system. A complex configured component may need more testing than a short piece of custom code.
What GAMP category is a spreadsheet?
The Second Edition covers end-user applications, including spreadsheets, in their own appendix, S3. The same logic applies: FDA’s software assurance guidance treats basic data entry in an off-the-shelf spreadsheet as low risk, but says custom formulas used directly in production or the quality management system may need further validation.
Is GAMP 5 a regulatory requirement?
No. It is an ISPE industry guide. The regulations, such as EU GMP Annex 11 and the US CGMP rules, require computerised systems to be validated for their intended use on the basis of risk. PIC/S guidance refers to the GAMP guide for detail, and FDA’s software assurance guidance lists GAMP 5 as one industry resource.
